The management of patients with lupus nephritis (LN) in clinical remission who demonstrate asymptomatic serological reactivation remains uncertain. Results from our previous study suggested that pre-emptive moderate increase of immunosuppressive treatment might reduce disease flares.
Kidney International published a clinical update in Research Highlights on 27 Mar 2026.
The item focuses on A prospective multi-center randomized controlled trial preemptive increase in immunosuppression for asymptomatic serological reactivation in patients with lupus nephritis in clinical remission.
Review the original article for the full source wording and details.